Literature DB >> 8161443

The application of quantitative polymerase chain reaction to therapeutic monitoring.

J J Sninsky1, S Kwok.   

Abstract

UNLABELLED: Use of polymerase chain reaction in HIV monitoring: The polymerase chain reaction can be used not only to detect the presence of viral sequences but also to provide a semiquantitative or a precise evaluation of the number of copies of genome present. Integral to the development of accurate and reproducible assays have been critical advances in polymerase chain reaction technology. In addition, standardization of protocols and reagents has proved invaluable. The HIV life cycle permits both DNA and RNA to be targeted. Although early cross-sectional studies provided little insight into disease progression, recent longitudinal studies have provided valuable information on HIV infection.
CONCLUSION: A rapid and simple quantitative assay for HIV RNA in plasma or sera has been developed that should prove valuable in determining the natural history of infection, dissecting viral pathogenesis and monitoring the efficacy of therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8161443     DOI: 10.1097/00002030-199311002-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Nanoliter scale PCR with TaqMan detection.

Authors:  O Kalinina; I Lebedeva; J Brown; J Silver
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

Review 2.  Comparison of competitive and positive control-based PCR quantitative procedures coupled with end point detection.

Authors:  F Mallet
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

3.  Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.

Authors:  F Damond; B Roquebert; A Bénard; G Collin; M Miceli; P Yéni; F Brun-Vezinet; D Descamps
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

Review 4.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

5.  Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay.

Authors:  F Mallet; C Hebrard; J M Livrozet; O Lees; F Tron; J L Touraine; B Mandrand
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

6.  Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load.

Authors:  P L Goldschmidt; A Devillechabrolle; Z Ait-Arkoub; J T Aubin
Journal:  Clin Diagn Lab Immunol       Date:  1998-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.